Corporate Crime ObservatoryAug 27, 20231 min readCSR BLOG: THE ASPARTAME DEBATE: ARE ECONOMIC INTERESTS CLOUDING THE TRUTH?
Corporate Crime ObservatoryMar 30, 20232 min readTHE COST OF MANIPULATION: THE IRRESPONSIBLE ABUSE OF TECHNOLOGICAL OPACITY IN BIG PHARMA